PET/CT helps predict survival in patients with breast cancer

03/11/2012 | MolecularImaging.net

Changes in 18F-FDG PET/CT standard uptake value measured before and again three months after selective internal radiation therapy can help predict survival in patients who have hepatic metastases due to breast cancer, according to a study in the Journal of Nuclear Medicine. Patients who responded to radioembolization survived longer than those who didn't, the study found.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY